StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health premiums Receivable — Allowance for Credit Losses / Doubtful Accounts ($M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
180
Period ended Sep 30, 2026
Change on a year earlier
+7.1%
168 in Q3 2025
History
32 quarters
Since Q4 2017
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPremiums Receivable — Allowance for Credit Losses / Doubtful Accounts ($M)Year on yearSource
Q3 2026Sep 30, 2026180+7.1%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q2 2026Jun 30, 2026187+14.7%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q1 2026Mar 31, 2026205+15.2%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q4 2025Dec 31, 2025167-8.7%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q3 2025Sep 30, 2025168-9.2%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q2 2025Jun 30, 2025163-7.9%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q1 2025Mar 31, 2025178-16.0%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q4 2024Dec 31, 2024183-13.7%ELV 10-K (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q3 2024Sep 30, 2024185-1.6%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q2 2024Jun 30, 2024177-3.8%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q1 2024Mar 31, 2024212+42.3%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q4 2023Dec 31, 2023212+39.5%ELV 10-K (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q3 2023Sep 30, 2023188+34.3%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q2 2023Jun 30, 2023184+34.3%ELV 10-Q/A (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q1 2023Mar 31, 2023149+6.4%ELV 10-Q (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗
Q4 2022Dec 31, 2022152+7.0%ELV 10-K (XBRL us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts) ↗

Cite this data

StockData. (2026). Elevance Health Premiums Receivable — Allowance for Credit Losses / Doubtful Accounts ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/bs_premium_receivables_allowance

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.